This was the best post of the day sparky. You are absolutely correct. This company just gave about 30% of the existing shareholders equity to a foreign entity in exchange for $60M cash. Additionally they gave 3 spots on the Board which will give them enormous power in the company. And this entity can produce a wide variety of LM products in Asia under the trademark name of Liquidmetal with no royalties coming back to the company (and shareholders).
So if you are a large medical company looking for a LM device, you can get the parts from Liquidmetal Technologies in the US or Europe (via Engel) which will bring revenue back to the company and shareholders. Or you can go to this company in China and purchase the LM parts from them (possibly at lower cost) and pay no royalties to the company or shareholders. So shareholders get nothing for LM devices made in China (or anywhere in Asia). That is not good for the shareholder as it in effect has created competition for ourselves, at our cost. Even if there is a huge medical contract in China, I cannot see how revenue gets back to this company and shareholder. Please someone correct me here if I am missing something.
At the end of the day, this just bought more time for the company to sell its products through Engel. At the cost of the shareholder. After reviewing this 8K, I still think Engel (and Apple) are the only hope for substantial revenue for this company and shareholder. Unless it comes up with new products and ways to manufacture the new products.
I still cannot figure out why they did this, especially if they have pending Engel contracts with pending revenues. Makes no sense to give up this much control of the company.
